Jian Zhang

ORCID: 0000-0003-1144-3627
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • HER2/EGFR in Cancer Research
  • Nutritional Studies and Diet
  • Healthcare and Venom Research
  • Advanced Breast Cancer Therapies
  • Diet and metabolism studies
  • Gene expression and cancer classification
  • Cancer, Hypoxia, and Metabolism
  • Safe Handling of Antineoplastic Drugs
  • Health, Environment, Cognitive Aging
  • Air Quality and Health Impacts
  • Nutrition and Health in Aging
  • Cell death mechanisms and regulation
  • Neuroblastoma Research and Treatments
  • Traditional Chinese Medicine Studies
  • Pediatric health and respiratory diseases
  • Pharmacy and Medical Practices

Sichuan University
2025

West China Hospital of Sichuan University
2025

Shanghai Medical College of Fudan University
2022

Harbin Medical University
2022

Second Affiliated Hospital of Harbin Medical University
2022

First Affiliated Hospital of Xi'an Jiaotong University
2020

Shandong First Medical University
2013

Breast cancer is now the most common malignant tumor worldwide. About one-fourth of female patients all over world suffer from breast cancer. And about one in six deaths worldwide caused by In terms absolute numbers cases and deaths, China ranks first world. The CACA Guidelines for Holistic Integrative Management Cancer were edited to help improve diagnosis comprehensive treatment China.

10.1007/s44178-022-00007-8 article EN cc-by Holistic Integrative Oncology 2022-07-05

Abstract Background Previous research results on the predictive factors of neoadjuvant chemotherapy (NCT) efficacy in breast cancer are inconsistent, suggesting that ability a single factor to predict is insufficient. Combining multiple potential efficacy-related build model may improve accuracy prediction. This study intends explore clinical and biological patients receiving NCT establish nomogram can pathologic complete response (pCR) rate NCT. Methods We selected 165 from July 2017 May...

10.1186/s12885-020-07621-7 article EN cc-by BMC Cancer 2020-11-19

Depression and diet are both common modifiable factors related to mortality rates among individuals with cancer, but their combined effects remained underexplored. We aimed comprehensively evaluate the independent joint association of depressive symptoms dietary patterns cancer survivors. A cohort US survivors (3,011 eligible participants, representing 20 million patients) were collected from National Health Nutrition Examination Survey (NHANES) between 2005 2018. Depressive assessed Patient...

10.1186/s12885-025-13945-z article EN cc-by-nc-nd BMC Cancer 2025-03-28

10.11569/wcjd.v12.i5.1136 article EN cc-by-nc Shijie huaren xiaohua zazhi 2004-01-01

Background: For N+ breast cancer patients treated with neoadjuvant therapy, the response to treatment, especially probability of axillary pathological complete (apCR), can guide choice subsequent surgical strategy.

10.26502/jcsct.5079224 article EN Journal of Cancer Science and Clinical Therapeutics 2024-01-01

Abstract Background Previous research results on the predictive factors of neoadjuvant chemotherapy (NCT) efficacy in breast cancer are inconsistent, suggesting that ability a single factor to predict is insufficient. Combining multiple potential efficacy-related build model may improve accuracy prediction. This study intends explore clinical and biological patients receiving NCT establish nomogram can pathologic complete response (pCR) rate NCT. Methods We selected 165 from July 2017 May...

10.21203/rs.3.rs-39809/v1 preprint EN cc-by Research Square (Research Square) 2020-07-07

Abstract Background Previous research results on the predictive factors of neoadjuvant chemotherapy (NCT) efficacy in breast cancer are inconsistent, suggesting that ability a single factor to predict is insufficient. Combining multiple potential efficacy-related build model may improve accuracy prediction. This study intends explore clinical and biological patients receiving NCT establish nomogram can pathologic complete response (pCR) rate NCT. Methods We selected 165 from July 2017 May...

10.21203/rs.3.rs-39809/v4 preprint EN cc-by Research Square (Research Square) 2020-11-11

Abstract Background Previous research results on the predictive factors of neoadjuvant chemotherapy (NCT) efficacy in breast cancer are inconsistent, suggesting that ability a single factor to predict is insufficient. Combining multiple potential efficacy-related build model may improve accuracy prediction. This study intends explore clinical and biological patients receiving NCT establish nomogram can pathologic complete response (pCR) rate NCT. Methods We selected 165 from July 2017 May...

10.21203/rs.3.rs-39809/v3 preprint EN cc-by Research Square (Research Square) 2020-10-14

Abstract BackgroundPrevious research results on the predictive factors of neoadjuvant chemotherapy (NCT) efficacy in breast cancer are inconsistent, suggesting that ability a single factor to predict is insufficient. Combining multiple potential efficacy-related build model may improve accuracy prediction. This study intends explore clinical and biological patients receiving NCT establish nomogram can pathologic complete response (pCR) rate NCT.MethodsWe selected 165 from July 2017 May 2019....

10.21203/rs.3.rs-39809/v2 preprint EN cc-by Research Square (Research Square) 2020-09-11
Coming Soon ...